Ravicti 1.1 g (Glycerol Phenylbutyrate LIQUID) 1.1 G

RAVICTI 1.1 G is a liquid formulation of glycerol phenylbutyrate used for managing certain metabolic conditions. This oral solution is designed to support patients requiring specialized care.

Strength

1.1 G

Pack Size

25ML

Manufacturer / TM Owner

HORIZON THERAPEUTICS IRELAND DAC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RAVICTI 1.1 G is primarily used to manage urea cycle disorders, which are conditions that affect the body's ability to remove ammonia from the bloodstream. This liquid formulation helps to reduce ammonia levels, supporting overall metabolic health. Patients often seek information on 'what is glycerol phenylbutyrate used for' when exploring treatment options for these disorders.

Side Effects

Common effects of RAVICTI 1.1 G may include gastrointestinal discomfort, such as nausea or vomiting. Some users might experience changes in appetite or taste. These effects can vary among individuals and are generally mild to moderate in nature.

Precautions & Warnings

RAVICTI 1.1 G should be handled with care, ensuring it is stored properly and administered as directed. It is important to follow the guidance of a healthcare provider regarding its use. Patients should be aware of potential interactions with other medications and should discuss their full medical history with their healthcare provider.

Avoid Interactions

RAVICTI 1.1 G may interact with certain medications, including those that affect liver function or metabolism. It is advisable to avoid alcohol while using this medication, as it can exacerbate side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Frequently Asked Questions

RAVICTI 1.1 G is used to manage urea cycle disorders, helping to reduce ammonia levels in the bloodstream.

RAVICTI 1.1 G is an oral liquid that should be taken as directed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, nausea, and changes in appetite or taste.

Patients should consult their healthcare provider before taking RAVICTI 1.1 G with other medications to avoid potential interactions.

The safety of long-term use should be discussed with a healthcare provider, who can provide personalized advice based on individual health conditions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.